Ulenistamab (PBP1510) is a first-in-class humanised IgG1 monoclonal antibody that specifically targets pancreatic adenocarcinoma upregulated factor (PAUF), Ulenistamab is extensively used in pancreatic cancer research to investigate PAUF-driven tumor progression, tumor microenvironment modulation, and antibody-based therapeutic strategies for pancreatic adenocarcinoma.
Purity:
95.00%
CAS Number:
[2415259-90-2]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted